Study to assess the knowledge of caretakers regarding corticosteroid therapy in children with congenital adrenal hyperplasia – 21 hydroxylase deficiency

BACKGROUND: The primary aim of treating congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency is to replace the deficient glucocorticoids and mineralocorticoids, to minimize the excess androgen production and to facilitate normal growth. Children with CAH require daily treatment life...

Descripción completa

Detalles Bibliográficos
Autores principales: Singarayan, Vasantha, David, Anita, Ayyar, Vageesh, James, Saji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491816/
https://www.ncbi.nlm.nih.gov/pubmed/32984131
http://dx.doi.org/10.4103/jfmpc.jfmpc_131_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491816/
https://www.ncbi.nlm.nih.gov/pubmed/32984131
http://dx.doi.org/10.4103/jfmpc.jfmpc_131_20

Ejemplares similares